Beware: Foot-and-Mouth Disease Outbreaks Emerging in Multiple Regions Worldwide

Recently, the global foot-and-mouth disease situation has been complex, with cases reported overseas. South Africa SAT‑1 The continued spread of virulent strains poses a severe import risk to China’s border ports and livestock production sectors. As one of the most devastating highly contagious animal diseases, foot-and-mouth disease is characterized by multiple serotypes, rapid mutation, and stealthy transmission, making it极易 to miss imported strains in routine testing. Scientific prevention and control, as well as precise traceability, depend on highly specific and highly sensitive molecular diagnostic tools.

The foot-and-mouth disease virus primarily targets more than 70 species of cloven-hoofed animals, including cattle, pigs, sheep, camels, and deer. Among these, cattle are the most susceptible, while pigs exhibit the highest transmissibility: the concentration of viral aerosols exhaled by infected pigs is thousands of times higher than that in cattle and sheep, making pigs a critical vector for disease spread. Sheep typically display milder clinical signs, which can easily go unnoticed, thereby turning them into silent “spreaders.” In addition, wild animals such as deer and antelopes may also serve as hosts; thus, cross-infection must be closely monitored to prevent the virus from spreading between livestock and wildlife.

Foot-and-mouth disease virus is highly contagious and spreads primarily through two main routes, both of which enable long-distance transmission—this is the core reason why it is so difficult to control:

*Direct contact: The blister fluid, saliva, milk, feces and urine, and exhaled breath of diseased or virus-carrying animals all contain high concentrations of the virus, making infection highly likely upon contact.

*Indirect contact: Feed, drinking water, tools, vehicles, clothing, and even the air contaminated by the virus can all serve as vectors of transmission. The virus can survive in contaminated environments for several months—longer in winter and about 14 days in summer.

The virus primarily enters the host body through the gastrointestinal and respiratory tracts, as well as via broken skin and mucous membranes in animals. The incubation period typically ranges from 1 to 7 days, with a maximum of up to 21 days. During the incubation period, infected animals may already begin shedding the virus, which significantly complicates prevention and control efforts—this is a key reason why outbreaks can spread rapidly.

For animal disease testing reagents, please choose the Weiboxin brand.

Be aware of Weiboxin Bio All products of!

Official consultation phone numbers: 020-82298089 / 135 3988 6748, Ms. Dai

Overseas Service Hotline (Mobile/WhatsApp/WeChat): +86 18902342201

Email: sara@viuick.com

Guangzhou Weiboxin Biotechnology Co., Ltd. is a high-tech enterprise specializing in the R&D, production, and sales of diagnostic reagents for animal infectious diseases. The company has been recognized as a “Technology Little Giant” enterprise, a “Contract-Honoring and Credit-Keeping Enterprise” of Guangdong Province, a provincial demonstration unit for intellectual property, and an executive director unit of the Veterinary Diagnostic and Biological Products Committee of the Guangdong Society of Animal Husbandry and Veterinary Medicine. It is also an innovation-potential enterprise certified by the Entrepreneurship College of Jinan University, a “Specialized, Refined, Distinctive, and Innovative” enterprise designated by both Guangdong Province and Guangzhou City, and a industry–university–research base of the Guangdong Vocational College of Food and Drug Administration. Furthermore, it has been awarded the titles of “High-Quality Service Provider for African Swine Fever and Other Porcine Disease Testing” and “Most Investment-Valuable Enterprise” by professional institutions.

The company has obtained multiple approval numbers for veterinary medicinal products from the Ministry of Agriculture and Rural Affairs, including: Veterinary Drug Approval No. 191438923 (Fluorescent PCR Test Kit for African Swine Fever Virus), Veterinary Drug Approval No. 191438213 (ELISA Antibody Test Kit for Porcine Reproductive and Respiratory Syndrome Virus), Veterinary Drug Approval No. 191438875 (Blocking ELISA Antibody Test Kit for Classical Swine Fever Virus), and Veterinary Drug Approval No. 191438851 (ELISA Antibody Test Kit for Porcine Circovirus Type 2), among others. Since its establishment, the company has been granted more than 40 patents in total, comprising over 30 invention patents, more than 10 utility model patents, and 4 design patents. The company has also successfully obtained ISO 9001 certification for the international quality management system and ISO 14001 certification for the international environmental management system.

Over the past several years, the company has consecutively been awarded such honors as the “Tax Credit Grade A Certificate,” the “Four-Star Trademark and Brand Certification,” and the “Two-Integration Management System Assessment Certificate.” It also received the Excellence Award in the Growth Category of the Biopharmaceutical Industry at the 11th China Innovation and Entrepreneurship Competition, secured the Provincial Second Prize in the Growth Category of the Nanotechnology Industry Technology Competition within the Science and Technology Innovation and Entrepreneurship Competition, and earned the National Third Prize in the Growth Category at the National Finals of the Nanotechnology Industry Technology Innovation Special Competition of the China Innovation and Entrepreneurship Competition.

The company focuses on the R&D, production, and sales of molecular diagnostic and immunoassay reagents for animal diseases, supported by a highly specialized team comprising dozens of masters, doctors, and professionals who have studied abroad. Leveraging its robust technical capabilities and world-class talent pool, the company has developed more than 800 products spanning molecular diagnostics, immunoassays, and other related fields. These include comprehensive molecular diagnostic kits for routine animal diseases covering all pathogen types, fully formulated lyophilized molecular diagnostic kits, immunoassay reagents for animal diseases, rapid-test kits, a complete line of nucleic acid extraction reagents (using magnetic-bead and spin-column methods, among others), as well as integrated instruments and equipment for rapid nucleic acid extraction and amplification in molecular diagnostics.

Currently, the company has established a nationwide distribution network centered on South China as its headquarters and leveraging key metropolitan hubs such as Beijing, Shanghai, Hangzhou, Nanjing, Xi’an, Chongqing, Lanzhou, Zhengzhou, and Qingdao as strategic nodes.

Quality is our lifeblood; innovation is our soul. Adhering to the business philosophy of “Customer First, Pursuit of Excellence, and Win-Win Cooperation,” the company harnesses technological innovation as its driving force, upholds rigorous management as its guarantee, and strives for world-class standards. Leveraging its own efficient industrial and technological strengths, we develop best-in-class products, deliver first-rate services, and build a premier corporate brand image, ensuring customer satisfaction with our offerings. We are committed to growing into a globally competitive, one-stop provider of molecular and rapid immunodiagnostic solutions for animal diseases.